Genesis Therapeutics

Genesis Therapeutics is at the forefront of drug discovery using a cutting-edge molecular AI platform. By integrating proprietary AI technology with physics research, their GEMS platform enables scientists to formulate drug candidates that target challenging protein structures with remarkable potency and selectivity. This process involves iterative, interdisciplinary collaborations across AI and biotech fields, aimed at tackling chemically complex problems in medicine efficiently. Designed to speed up the discovery process, Genesis Therapeutics' approach provides new hope for developing medicines that were previously beyond reach, offering breakthrough solutions for healthcare challenges.